Key examination steps before lapatinib treatment

Lapatinib, also known as lapatinib tosylate, is an oral, small molecule tyrosine kinase inhibitor targetingHER2-positive advanced breast cancer. It effectively inhibits the proliferation of tumor cells by blocking the HER2 signaling pathway. To ensure the safety and effectiveness of treatment, patients need to undergo a series of detailed examinations before starting lapatinib treatment.

The first priority is genetic testing. SinceHER2 positivity is a prerequisite for lapatinib treatment, the patient's HER2 status must be confirmed through accurate genetic testing. Once HER2 positivity is confirmed, lapatinib is a treatment option. At the same time, for other cancer types such as non-small cell lung cancer and colorectal cancer, further testing of EGFR mutations, ALK and ROS1 gene fusions is needed to determine the applicability of lapatinib or other targeted drugs.

Next, imaging tests play a vital role. Using chest CT, abdominal ultrasound, and bone scan, we can accurately locate the primary tumor and evaluate its size and whether there is metastasis. These data provide strong support for disease judgment, treatment plan formulation and efficacy evaluation.

Blood tests are also essential. Routine blood tests help monitor changes in the number of white blood cells, red blood cells, and platelets, and detect signs of anemia or infection in a timely manner. Liver and renal function tests are used to evaluate the metabolism and excretion functions of the liver and kidneys to ensure that lapatinib can be metabolized normally in the body. If abnormal liver and kidney function are found, the doctor can adjust the drug dosage or change the treatment plan accordingly.

Finally, electrocardiogram examination is also a key step. Considering that some targeted drugs may cause cardiotoxicity, it is important to perform an electrocardiogram before starting treatment to identify and prevent potential heart disease risks.

In summary, comprehensive examination and evaluation before lapatinib treatment is the cornerstone to ensure the safety and effectiveness of treatment. These examinations cover genetic testing, imaging examinations, blood tests and electrocardiogram examinations, etc., providing doctors with a window into a comprehensive understanding of the patient's condition and physical condition, so that they can develop personalized treatment plans that better suit the patient's needs.